TRBC1 and angioimmunoblastic T-cell lymphoma: Using PD-1 and TRBC1 combined with pan-T cell antibodies can make a precise diagnosis of AITL and monitor minimal residual lesions regardless of the antigenic drift of neoplastic T cells.